Bioabsorbable Therapeutics Scores Series B
Menlo Park-based Bioabsorable Therapeutics announced today that the firm has raised $9M in a Series B round. The investment came from Finistere Ventures and ITX International Equity. The firm is developing a biodegradable polymer used for coronary stents. The funding will go towards human clinical trials.
posted on Thursday, May 10, 2007 (Link to more information)
Related companies:
Bioabsorbable Therapeutics
Related stories:
> Iconic Therapeutics Adds $10M To Series C
> Iconic Therapeutics Finds $20M
> Coapt Systems Raises $22.6M
> CytomX Therapeutics Raises $41M
> Arete Therapeutics Raises $35M
silicontap.com Home